Porcine Therapeutics

Porcine Therapeutics is a biotechnology company focused on developing genetically modified porcine organs for human transplantation, a field known as xenotransplantation. The company leverages advanced gene-editing technologies to create donor animals with reduced immunogenicity and improved compatibility with the human immune system. By addressing the critical shortage of human donor organs, Porcine Therapeutics aims to provide life-saving solutions for patients suffering from end-stage organ failure. Their research primarily targets the development of porcine kidneys, hearts, and livers that can function effectively in human recipients without triggering hyperacute rejection.